• Users Online: 56
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Contacts Login 
ARTICLE
Year : 2016  |  Volume : 8  |  Issue : 3  |  Page : 73-80

Effects of simvastatin and omega 3-fatty acids on blood pressure, plasma lipid profiles, liver and renal function in type 2 diabetes


1 Department of Internal Medicine, Faculty of Medicine, University of Benghazi, Benghazi, Libya
2 Department of Internal Medicine (Nephrology), Faculty of Medicine, University of Omar El Mukhtar, Al Baidha, Libya
3 Department of Pharmacology, Faculty of Medicine, University of Benghazi, Benghazi, Libya
4 Department of Physiology, Faculty of Public Health, University of Benghazi, Benghazi, Libya
5 Department of Biochemistry, Faculty of Public Health, University of Benghazi, Benghazi, Libya

Correspondence Address:
Mustafa YG Younis
Department of Biochemistry, Faculty of Public Health, University of Benghazi, Benghazi
Libya
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1947-489X.210220

Rights and Permissions

A group of patients with and hyperlipidemia were divided into male and female groups and further subdivided into 3 groups. These groups received, either simvastatin (20 mg daily), Omega3-fatty acid (2g/day), or both. The blood pressure and lipid profile were measured before and after 4 weeks of treatment. Our data showed that treatment with simvastatin did not produce significant effect on blood pressure, however the blood pressure was significantly reduced in patients received omega 3-fatty acid or simvastatin plus omega3-fatty acid. The total cholesterol (TC), triglycerides (TG), and low density lipoprotein (LDL) significantly decreased in all treated groups. The high density lipoprotein (HDL) significantly increased in all treated groups except in the group of males receiving simvastatin. Alanine transaminase (ALT) increased significantly in female and male groups receiving simvastatin, but significantly decreased in same groups receiving omega 3-fatty acid and in the males receiving simvastatin plus omega3-fatty acid. The aspartate transaminase (AST) levels significantly decreased in all treated groups except in the female group given omega3-fatty acid. The alkaline phosphatase (ALP) significantly increased only in the groups given simvastatin alone. The levels of urea and creatinine were not affected in all groups. In our prospective study we found that simvastatin decreased TC, TG and LDL, and resulted in elevation of liver transaminases. Omega3- fatty acid alone or in combination with simvastatin has similar effect on lipid profile and it significantly reduces blood pressure without affecting liver or renal function.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed539    
    Printed30    
    Emailed0    
    PDF Downloaded90    
    Comments [Add]    

Recommend this journal